Mechanistic Questions

What is the primary molecular target of PT-141?

How does MC4R activation lead to sexual readiness?

Why does PT-141 not require sexual stimulation?

What is the pharmacokinetic half-life of bremelanotide?

How does bremelanotide differ from melanocyte-stimulating hormone (α-MSH)?

Is PT-141 the same as the Melanotan peptides?

What does 'central arousal readiness' mean mechanistically?

What is the FDA-approved indication for bremelanotide?

What are the primary adverse effects documented in clinical trials?

Does PT-141 interact with CYP450 enzymes?